Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

BPMUF

Basilea Pharmaceutica AG

USD

Set alert

Price alert · BPMUF

All alert types
76.25 USD 0.00 0.00%
As of Oct 30, 2026
77.40 Day range 77.40
59.29 52-week range 77.40
YTD
+20.55%
1 year
+27.15%
Open
77.40
Prev close
76.25
Mkt cap
945.05M
Vol
100
Avg vol
6
EPS
5.05
P/E
15.10
More statistics
Low
77.40
High
77.40

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for BPMUF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

1.88 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

8 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A-4 / 5 overall

  • DCF 4
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 2
  • P/E 3
  • P/B 2

Valuation

P/E 15.2×
FY 2016: -14.3×FY 2017: -42.2×FY 2018: -13.4×FY 2019: -23.1×FY 2020: -37.4×FY 2021: -64.4×FY 2022: 47.1×FY 2023: 40.1×FY 2024: 7.5×FY 2025: 15.2×
FY 2016 5y median 15.2× FY 2025
P/S 2.6×
FY 2016: 11.1×FY 2017: 8.1×FY 2018: 3.2×FY 2019: 3.8×FY 2020: 4.3×FY 2021: 2.9×FY 2022: 3.9×FY 2023: 2.7×FY 2024: 2.8×FY 2025: 2.6×
FY 2016 5y median 2.8× FY 2025
P/B 4.8×
FY 2016: -20.9×FY 2017: -19.8×FY 2018: -6.3×FY 2019: -5.6×FY 2020: -5.4×FY 2021: -7.5×FY 2022: -12.7×FY 2023: -41.9×FY 2024: 7.2×FY 2025: 4.8×
FY 2016 5y median -7.5× FY 2025
P/FCF 10.3×
FY 2016: -9.7×FY 2017: 45.4×FY 2018: -5.3×FY 2019: -8.0×FY 2020: -9.7×FY 2021: -13.3×FY 2022: 152×FY 2023: 31.7×FY 2024: 8.0×FY 2025: 10.3×
FY 2016 5y median 10.3× FY 2025
EV/EBITDA 13.2×
FY 2016: -16.6×FY 2017: -93.2×FY 2018: -26.0×FY 2019: -42.3×FY 2020: -124×FY 2021: 160×FY 2022: 30.7×FY 2023: 21.0×FY 2024: 8.6×FY 2025: 13.2×
FY 2016 5y median 21.0× FY 2025
EV/Sales 2.9×
FY 2016: 10.4×FY 2017: 9.5×FY 2018: 4.4×FY 2019: 4.5×FY 2020: 5.7×FY 2021: 4.1×FY 2022: 4.6×FY 2023: 3.1×FY 2024: 2.7×FY 2025: 2.9×
FY 2016 5y median 3.1× FY 2025
FCF Yield 9.7%
FY 2016: -10.3%FY 2017: 2.2%FY 2018: -19.0%FY 2019: -12.4%FY 2020: -10.3%FY 2021: -7.5%FY 2022: 0.7%FY 2023: 3.2%FY 2024: 12.5%FY 2025: 9.7%
FY 2016 5y median 3.2% FY 2025

Profitability

Gross Margin 83.1%
FY 2016: 91.9%FY 2017: 91.1%FY 2018: 84.7%FY 2019: 86.0%FY 2020: 81.2%FY 2021: 83.7%FY 2022: 83.3%FY 2023: 83.0%FY 2024: 81.5%FY 2025: 83.1%
FY 2016 5y median 83.1% FY 2025
Operating Margin 22.2%
FY 2016: -66.5%FY 2017: -13.9%FY 2018: -18.2%FY 2019: -12.8%FY 2020: -6.4%FY 2021: 0.8%FY 2022: 12.5%FY 2023: 12.2%FY 2024: 29.3%FY 2025: 22.2%
FY 2016 5y median 12.5% FY 2025
Net Margin 17.3%
FY 2016: -77.7%FY 2017: -19.1%FY 2018: -23.7%FY 2019: -16.7%FY 2020: -11.5%FY 2021: -4.6%FY 2022: 8.2%FY 2023: 6.6%FY 2024: 37.2%FY 2025: 17.3%
FY 2016 5y median 8.2% FY 2025
ROE 31.4%
FY 2016: 146.5%FY 2017: 46.7%FY 2018: 47.0%FY 2019: 24.1%FY 2020: 14.4%FY 2021: 11.7%FY 2022: -27.0%FY 2023: -104.5%FY 2024: 95.8%FY 2025: 31.4%
FY 2016 5y median 11.7% FY 2025
ROIC 19.1%
FY 2016: -17.2%FY 2017: -6.4%FY 2018: -12.7%FY 2019: -11.8%FY 2020: -5.4%FY 2021: 0.6%FY 2022: 10.0%FY 2023: 13.4%FY 2024: 28.6%FY 2025: 19.1%
FY 2016 5y median 13.4% FY 2025
ROA 14.3%
FY 2016: -15.6%FY 2017: -5.5%FY 2018: -11.1%FY 2019: -10.1%FY 2020: -6.4%FY 2021: -2.8%FY 2022: 5.5%FY 2023: 6.0%FY 2024: 30.1%FY 2025: 14.3%
FY 2016 5y median 6.0% FY 2025

Growth (YoY)

Revenue 11.5%
FY 2016: 27.7%FY 2017: 53.9%FY 2018: 30.6%FY 2019: 1.4%FY 2020: -5.0%FY 2021: 16.1%FY 2022: -0.2%FY 2023: 6.7%FY 2024: 32.3%FY 2025: 11.5%
FY 2016 FY 2025
Operating Income -15.6%
FY 2016: 30.0%FY 2017: 67.8%FY 2018: -70.5%FY 2019: 28.6%FY 2020: 52.2%FY 2021: 114.4%FY 2022: 1462.2%FY 2023: 3.6%FY 2024: 218.5%FY 2025: -15.6%
FY 2016 FY 2025
EPS (diluted) -46.1%
FY 2016: 16.7%FY 2017: 64.7%FY 2018: -61.5%FY 2019: 28.0%FY 2020: 31.3%FY 2021: 59.4%FY 2022: 275.9%FY 2023: -15.7%FY 2024: 577.9%FY 2025: -46.1%
FY 2016 FY 2025
Free Cash Flow -18.0%
FY 2016: -9.2%FY 2017: 124.0%FY 2018: -541.7%FY 2019: 19.5%FY 2020: 12.2%FY 2021: 41.7%FY 2022: 111.4%FY 2023: 252.0%FY 2024: 449.3%FY 2025: -18.0%
FY 2016 FY 2025

Financial Health

Current Ratio 5.1×
FY 2016: 3.7×FY 2017: 3.7×FY 2018: 4.1×FY 2019: 2.4×FY 2020: 4.5×FY 2021: 1.4×FY 2022: 2.3×FY 2023: 3.2×FY 2024: 4.8×FY 2025: 5.1×
FY 2016 5y median 3.2× FY 2025
Quick Ratio 4.7×
FY 2016: 3.5×FY 2017: 3.5×FY 2018: 3.9×FY 2019: 2.2×FY 2020: 4.0×FY 2021: 1.3×FY 2022: 2.0×FY 2023: 2.6×FY 2024: 4.2×FY 2025: 4.7×
FY 2016 5y median 2.6× FY 2025
Debt / Equity 0.7×
FY 2016: -5.6×FY 2017: -4.7×FY 2018: -3.0×FY 2019: -2.1×FY 2020: -2.4×FY 2021: -3.7×FY 2022: -4.2×FY 2023: -12.9×FY 2024: 1.4×FY 2025: 0.7×
FY 2016 5y median -3.7× FY 2025
Net Debt / EBITDA 1.2×
FY 2016: 1.1×FY 2017: -14.1×FY 2018: -7.1×FY 2019: -6.2×FY 2020: -30.8×FY 2021: 43.9×FY 2022: 4.7×FY 2023: 3.0×FY 2024: -0.1×FY 2025: 1.2×
FY 2016 5y median 3.0× FY 2025
Interest Coverage 15.4×
FY 2016: -6.8×FY 2017: -2.1×FY 2018: -3.7×FY 2019: -2.0×FY 2020: -1.1×FY 2021: 0.1×FY 2022: 1.9×FY 2023: 1.7×FY 2024: 14.1×FY 2025: 15.4×
FY 2016 5y median 1.9× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31